A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, led by researchers at UCL and Newcastle University. The £26 million project ...

Transplanting dopamine-releasing neurons into the brain is a promising regenerative therapy for Parkinson’s disease. Two clinical trials show that it is safe, but more evidence is needed to prove its ...

SAN FRANCISCO--(BUSINESS WIRE)--Rune Labs, the leader in precision medicine for Parkinson’s disease (PD), today announced the launch of a clinical program with Parkinson’s Foundation to accelerate the ...